Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REVUMENIB vs RIBASPHERE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REVUMENIB vs RIBASPHERE: Safety Overview

Metric REVUMENIB RIBASPHERE
Total FAERS Reports 371 123
Deaths Reported 49 2
Death Rate 13.2% 1.6%
Hospitalizations 93 19
Average Patient Age 46.4 yrs 55.6 yrs
% Female Patients 47.6% N/A
FDA Approval Date Nov 15, 2024 N/A
Manufacturer Syndax Pharmaceuticals, Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A